You are here

Guidelines

New Medication Options for Patients With Type-2 Diabetes
Overeager Use of Recommendations Creates Problems
Scrotal Ultrasound and Obtaining Serum Tumor Markers Among 45 Recommendations
New Resource Offers Best Practices for Capturing Data to Support FDA’s UDI Rule
American College of Physicians ups A1c limit to 8%
New NCCN guidelines seek to reduce unnecessary, deadly cancer care gaps
Detailed procedures aim to protect patients from promising treatment’s toxicities
Dual testing no longer needed; screening interval can be up to 5 years
Simplified tables from American Academy of Pediatrics likely to raise detection rates
Medically supervised withdrawal is an option, but not the first one
Surgery did not improve mortality outcomes in patients with localized disease
Controversies are critiqued and data-derived recommendations are proposed
Definition of the disease becomes more precise
Availability of agents will alleviate lengthy negotiation process
Statement supports fewer vaccinations, urges action to increase vaccination rates
Recommendations aim to safeguard physical and psychological health
Treatment is beneficial for patients 40 to 75 years of age with CVD risks
First stakeholder meeting to be held this month
Endocrine Society publishes guideline evaluating technologies for treating diabetes
Experts set groundwork for ‘moonshot’ initiative
Experts find little evidence to support routine screening in adults
New guidance recommends vaccinating boys and girls at ages 11 to 12
Experts recommend seven or fewer days of therapy
Study evaluates USPSTF guidelines in clinical practice
Metoclopramide, prochlorperazine, and sumatriptan top the list